Analyst Research Roundup: Accenture plc (ACN), Walgreens Boots Alliance, Inc. (WBA)

Many analysts have provided their estimated foresights on Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 2.0% during the first quarter, according to its most recent filing with the SEC. The fund owned 123,418 shares of the pharmacy operator’s stock after selling 787 shares during the period. Loop Capital assumed coverage on shares of Walgreens Boots Alliance in a report on Thursday.

Several other large investors have also recently modified their holdings of WBA. Finally, Prudential Financial Inc. boosted its position in Walgreens Boots Alliance by 53.0% in the first quarter. Of those analysts, 9 rate stock as a Strong Buy, 2 rate it as Hold, and just no analyst rates it as a Moderate Sell.

Walgreens Boots Alliance, a holding company.

According to Finviz reported data, The SMA20 of the stock is at 0.32 percent, SMA50 is 2.18 percent, while SMA200 is -1.86 percent. The Return on Equity ratio of Walgreens Boots Alliance, Inc. Swiss National Bank now owns 3,262,703 shares of the pharmacy operator’s stock valued at $270,967,000 after buying an additional 700,400 shares in the last quarter. Hudock Capital Group LLC raised its stake in shares of Walgreens Boots Alliance by 0.4% in the first quarter. The firm owned 39,429 shares of the pharmacy operator’s stock after buying an additional 7,383 shares during the period. Future earnings predictions are perhaps the most essential input when trying to value a company.

FT reports, The 25 analysts offering 12 month price targets for Accenture Plc have a median target of 134.00, with a high estimate of 145.00 and a low estimate of 110.00. (WBA) has surged 0.78% and closed its last trading session at $81.13. 03, 2017. The company’s shares were given away at $85.89 per share worth to an income of some $234,995 on account of Foote William C. Walgreens Boots Alliance, Inc. The firm has a market capitalization of $87.19 billion, a price-to-earnings ratio of 20.58 and a beta of 1.25. If we take a wider approach, shares have been trading -1.83% away from the 200-day moving average.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, June 29th. To make a proper assessment, investors seek a sound estimate of this year’s and next year’s earnings per share (EPS), as well as a strong sense of how much the company will earn even farther down the road. Comparatively, WBA posted earnings of $0 per share in the same quarter, a year earlier. The business’s revenue was up 2.1% on a year-over-year basis.

Walgreens Boots Alliance, Inc. on 5/30/2017 reported its EPS as $1.07 with the analysts projecting the EPS of the stock as $0.99.

Walgreens Boots Alliance announced that its board has approved a stock repurchase program on Thursday, June 29th that allows the company to buyback $5.00 billion in shares. Shares buyback programs are typically an indication that the company’s board of directors believes its stock is undervalued. Investors of record on Friday, August 18th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Wednesday, August 16th. This represents a $1.60 annualized dividend and a dividend yield of 1.97%. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s payout ratio is presently 40.30%.

ILLEGAL ACTIVITY WARNING: This article was first published by StockNewsTimes and is owned by of StockNewsTimes.

Shares of Walgreens Boots Alliance, Inc.

Several analysts have recently commented on WBA shares. Needham & Company LLC set a $94.00 price target on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Monday, July 17th. Finally, Credit Suisse Group reiterated a “buy” rating and set a $97.00 price target on shares of Walgreens Boots Alliance in a research report on Thursday, July 13th. At current levels, The Goldman Sachs Group, Inc. “Ultimately, through all this investigation into the company’s performance the analyst decides if their stock is a “buy”, sell” or hold”. They set a “buy” rating and a $95.00 target price on the stock. The company have shares float of 924.60 million. After this purchase, 1,697,438 common shares of WBA are directly owned by the insider, with total stake valued at $137,764,068. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 13.50% of the company’s stock. The Pharmaceutical Wholesale segment consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. The Company is a global pharmacy-led, health and wellbeing enterprise.

Leave a Reply

Your email address will not be published. Required fields are marked *